ERBB2 and neoplasm: Therefore, we investigated whether phototherapy using IR700-based HER2-targeted affibody conjugate could (i) promote the release of DAMPs capable of inducing maturation of DCs in vitro and, (ii) delay tumour growth in receptor-positive xenografts.